Byrne Asset Management LLC Tandem Diabetes Care Inc Transaction History

Byrne Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$35.49 - $56.15 $1,419 - $2,246	40 Added 66.67%	100 $4,000
Q3 2022 Oct 19, 2022	SELL	$43.76 - $68.97 $2,844 - $4,483	-65 Reduced 52.0%	60 $3,000
Q2 2022 Jul 20, 2022	SELL	$53.22 - $123.09 $5,322 - $12,309	-100 Reduced 44.44%	125 $7,000
Q4 2021 Feb 22, 2022	BUY	$118.18 - $153.21 $26,590 - $34,472	225 New	225 $34,000

352

73M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.38B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Byrne Asset Management LLC with notifications on news.